http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201116627-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4396e2fefb8831bad6e7fca2547c6bca |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 |
filingDate | 2005-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea3f2d6572c23959cd71365d985f87b3 |
publicationDate | 2011-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-201116627-A |
titleOfInvention | Recombined swine fever virus E2 glycoprotein, monoclonal antibody thereof, application in diagnosis agent and sub-unit vaccine |
abstract | The invention relates to utilize a baculovirus express system in an insect cell to produce a recombined E2 glycoprotein originated from an isolated strain of type II swine fever virus of classical swine fever virus (CSFV). The produced recombined E2 glycoprotein is characterized in that the immune responses generated in pigs are similar to that infected by wild swine fever virus. The invention also discloses a specific monoclonal antibody TY125 prepared from the recombined E2 glycoprotein, which can simultaneously recognize swine fever virus stains of different molecule subtypes, such as LPC, S-59, TD/96/TWN, 0406/CH/01/TWN, 38/KS/93/TWN and 94.4/IL/94/TWN. The invention also relates to the applications of using the produced recombined E2 glycoprotein and monoclonal antibody thereof for preparing the swine fever diagnosis agents sub-unit identification vaccines. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103588864-A |
priorityDate | 2005-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 381.